ResearcherFirst Affiliated Hospital of Xi'an Jiaotong UniversityNo recent work listed

Hui Guo

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5110256552. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2022: 1 paper · 2023: 1 paper

Papers 2

Integrated single-cell and bulk RNA sequencing revealed the molecular characteristics and prognostic roles of neutrophils in pancreatic cancer. Co-author DOI 10.18632/aging.205044 ↗
SGLT-2 as a potential target in pancreatic cancer: the preliminary clue from The Cancer Genome Atlas data. Last author DOI 10.21037/jgo-22-900 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Biao Zhang · 1 shared paper, 2023 · strength 0.19
- Paper Integrated single-cell and bulk RNA sequencing revealed the molecular characteristics and prognostic roles of neutrophi… DOI 10.18632/aging.205044 ↗
Qihang Yuan · 1 shared paper, 2023 · strength 0.19
- Paper Integrated single-cell and bulk RNA sequencing revealed the molecular characteristics and prognostic roles of neutrophi… DOI 10.18632/aging.205044 ↗
Xu Chen · 1 shared paper, 2023 · strength 0.19
- Paper Integrated single-cell and bulk RNA sequencing revealed the molecular characteristics and prognostic roles of neutrophi… DOI 10.18632/aging.205044 ↗
Wei Qiang · 1 shared paper, 2022 · strength 0.16
- Paper SGLT-2 as a potential target in pancreatic cancer: the preliminary clue from The Cancer Genome Atlas data. DOI 10.21037/jgo-22-900 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.